Raseen Tariq, MD, MS

#AI is reshaping #IBD care, from diagnosis to personalized therapy. Our review explores innovation in AI-powered classification, monitoring and treatment optimization journals.sagepub.com/doi/10.1177/17… @TAGastroenterol @IBD_Afzali @NasimParsaMD @VCUHealth @VCU_Liver

Thank you @KaazanPatricia @jalpa_devi for supporting our team at @ASGEendoscopy #AIGI scholars program. 3 non-funded ideas, one year mentorship and didactic program, many new friends! @tariqraseen Bahaa Thank you for our leaders @AliSoroushMD @sravmd #DDW2025

@tariqraseen @JosephHabibi_MD & his team @ASGEendoscopy #AIforGI

Inspiring day at the 29th Annual Virginia GI Symposium and Liver Update by @VCUHealth! 🎤📚 Truly honored to celebrate Dr. Alvin Zfass — a pioneer in #Endoscopy and #GI, mentor to 200+ fellows, and a lifelong champion for trainees. 🏆🙏 A legacy that continues to inspire us all!…

✨ @tariqraseen, Dr Bickston and Dr Mangray discussing IBD at the 29th Virginia Liver Symposium & Update in Gastro @VCUHealth ✅ safest therapy is the one effectively controls disease @AmCollegeGastro @AGA_Gastro @AASLDtweets

Our study of GI trainees & early career physicians found strong interest in AI but low confidence & limited use. Structured AI education is needed in GI training to close the gap!! @Khanna_S @tberzin @AliSoroushMD @AdvaniRashmiMD link.springer.com/article/10.100…

An effective day brainstorming and learning - for both the scholars & the mentors As our guest lecturer @ulasbagci says " AI will not replace physicians, but physicians who learn AI will replace them in healthcare research" Thanks @ASGEendoscopy ! -with @AliSoroushMD

THANK YOU to ALL our national & international faculty, participants, sponsors and exhibitors @MayoClinic Innovations in Gastroenterology and Hepatology 2024 course! If AI and innovation is 🎶 to your👂and your 🧠 is full of new 💡 join us next year! 🙌 Save the date for 2025!

Thank you @ASGEendoscopy and the program directors @AliSoroushMD @sravmd for the opportunity!!!

In #CTGjournal: Machine Learning-based Prediction Models for C difficile Infection: A Systematic Review Tariq, et al. ➡️ bit.ly/3yCxPRW @tariqraseen @RenishaRedij @ShivaramPoigai @FaubionWilliam @Khanna_S @AmCollegeGastro @brianjacobsonmd

@tariqraseen ⭐️ GI fellow @MayoClinic presents on employing automated machine learning to predict bowel surgery risk in #IBD patients with C. difficile @DDWMeeting

Thank you @Khanna_S @DarrellPardi @DougSimonetto for all the mentorship and support!!!

@MayoClinicGIHep super ⭐️ fellow @tariqraseen using AI to decode outcomes of C. difficile and #IBD @DDWMeeting Elegant solutions to tough problems! #DDW2024

Machine Learning-based Prediction Models for C difficile Infection journals.lww.com/ctg/abstract/9… Standardized definitions and external validation is needed to increase utility of AI models. @Khanna_S @FaubionWilliam @MayoClinicGIHep

Integrating Clinical Guidelines With ChatGPT-4 Enhances Its’ Skills @MayoProceedings mcpdigitalhealth.org/article/S2949-… @Khanna_S @EliVothMD

We are so excited to introduce the @IBDJournals fellows corner! ✍️ 📚 📖 📕 ✏️ Take a look at the goals of the corner and submit your original articles #physicianscientist #IBD #crohnscolitis #earlycareerresearchers

Check out what our 2023 @IBDJournals Editorial Fellows @biancaislam and @tariqraseen launched during their Editorial Fellowship this past year for #IBDJournal doi.org/10.1093/ibd/iz…

Delighted to kick start ⁦@GuildConference⁩ with the future of Gastroenterolgy— mentoring fellows and learning about their career paths and interests— what a beautiful morning with the brightest of minds ⁦@MLongMD⁩ ⁦@BlaneyMD⁩ ⁦@UmaMahadevanIBD⁩

@IBDJournals had their annual in-person Associate Editor meeting @CrohnsColitisFn #CCCONGRESS24. 📸 Drs. Editor in Chief Fabio Cominelli & Deputy Editor @sonia_friedman with editorial fellows @biancaislam & @tariqraseen. Many Thanks to the Board, editors, reviewers, & our authors

Thank you @EdwardLoftus2, @DarrellPardi for the collaboration! @tariqraseen - Excellent work as always #FMT for recurrent #Cdiff is safe and durable in people with moderate to severe #IBD